Pfizer Sells Capsugel Unit for $2.4 Billion

By Tess Stynes Kohlberg Kravis Roberts & Co. agreed to acquire Pfizer (NYSE:PFE) Like many large pharmaceutical companies, Pfizer is facing generic competition on some of its biggest-selling drugs in coming years and has been adjusting its strategy...